RADNOSTIX INC (INIS)
Sector: Industrial Instruments For Measurement, Display, and Control
Industry: Drug Manufacturers - Specialty & Generic
Radnostix, Inc.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 17, 2026 | 0.0400 | 0.0400 | 0.0351 | 0.0351 | 100,000 |
| Nov 16, 2026 | 0.0390 | 0.0390 | 0.0385 | 0.0385 | 9,726 |
| Nov 11, 2026 | 0.0408 | 0.0479 | 0.0408 | 0.0479 | 244 |
| Nov 10, 2026 | 0.0432 | 0.0432 | 0.0432 | 0.0432 | 700 |
| Nov 9, 2026 | 0.0390 | 0.0390 | 0.0384 | 0.0385 | 45,750 |
| Nov 6, 2026 | 0.0400 | 0.0479 | 0.0390 | 0.0390 | 35,062 |
| Nov 5, 2026 | 0.0493 | 0.0493 | 0.0380 | 0.0380 | 104,619 |
| Nov 3, 2026 | 0.0492 | 0.0492 | 0.0492 | 0.0492 | 6,200 |
| Nov 2, 2026 | 0.0465 | 0.0465 | 0.0400 | 0.0400 | 411,725 |
| Oct 30, 2026 | 0.0400 | 0.0490 | 0.0400 | 0.0463 | 3,120 |
| Oct 29, 2026 | 0.0446 | 0.0446 | 0.0401 | 0.0401 | 2,700 |
| Oct 28, 2026 | 0.0389 | 0.0400 | 0.0389 | 0.0400 | 85,000 |
| Oct 27, 2026 | 0.0493 | 0.0493 | 0.0375 | 0.0390 | 587,146 |
| Oct 26, 2026 | 0.0493 | 0.0493 | 0.0493 | 0.0493 | 17,500 |
| Oct 23, 2026 | 0.0475 | 0.0493 | 0.0404 | 0.0493 | 12,507 |
| Oct 22, 2026 | 0.0404 | 0.0493 | 0.0404 | 0.0423 | 15,200 |
| Oct 21, 2026 | 0.0405 | 0.0493 | 0.0405 | 0.0493 | 2,000 |
| Oct 20, 2026 | 0.0480 | 0.0493 | 0.0470 | 0.0470 | 49,946 |
| Oct 19, 2026 | 0.0450 | 0.0470 | 0.0448 | 0.0470 | 264,300 |
| Oct 15, 2026 | 0.0450 | 0.0450 | 0.0450 | 0.0450 | 80,000 |
| Insider | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Director | Grant/Award | 250.0K | -- | Oct 10, 2025 | |
| Director | Grant/Award | 500.0K | -- | Oct 10, 2025 | |
| Director | Grant/Award | 500.0K | -- | Oct 10, 2025 | |
| Pres. & CEO | Grant/Award | 37.50M | -- | Oct 9, 2025 | |
| Pres. & CEO | Purchase | 140.0K | $7.0K | May 22, 2025 | |
| Pres. & CEO | Automatic Sell | 583.2K | $29.2K | Apr 24, 2025 |
| Name | Shares | % | Source |
|---|---|---|---|
GROSSO CHRISTOPHER G Director, 10% Owner | 38.5M | 7.1% | FORM 4 |
Bagerdjian Shahe Pres. & CEO, Director | 9.0M | 1.7% | FORM 4 |
Atcher Robert Director | 1.0M | 0.2% | FORM 4 |
COX W MATTHEW Chief Financial Officer | 897.7K | 0.2% | FORM 4 |
Capital Square, LLC | 20.0K | 0.0% | 13F |
Insiders
- Atcher RobertDirector
- GROSSO CHRISTOPHER GDirector
- Laflin SteveDirector
- Bagerdjian ShahePres. & CEO
- COX W MATTHEWChief Financial Officer
Top institutional holders
Radnostix, Inc. (INIS) is a company that specializes in the global manufacturing and sale of crucial nuclear medicine calibration and reference standards, cobalt-60 products, and offers contract services for producing radiopharmaceuticals and radiochemicals.
Its operations are structured into five key divisions: Nuclear Medicine Standards, Cobalt Products, Radiochemical Products, Radiological Services, and Fluorine Products. The Nuclear Medicine Standards segment is responsible for creating various sources and standards essential for single photon emission computed tomography (SPECT) and positron emission tomography (PET) imaging, accurate patient positioning, and for calibrating or testing the performance of dose-measuring equipment within the nuclear pharmacy industry. This segment's product range includes flood sources, dose calibrators, rod sources, flexible and rigid rulers, precision spot and pen point markers, and numerous custom-designed items. The Cobalt Products division processes bulk cobalt, fabricates cobalt capsules for use in radiation therapy and diverse industrial applications, and is involved in the recycling of depleted cobalt sources. Through its Radiochemical Products segment, Radnostix develops and supplies a variety of highly pure radiochemicals, along with the generic drug product sodium iodide I-131, serving medical, industrial, and research applications. The Radiological Services segment offers specialized services such as the safe disposal of flood sources and the intricate processing of gemstones. Finally, the Fluorine Products segment focuses on producing small-scale, high-purity fluoride gas samples for qualification in various industrial applications.
It also undertakes the development of critical laboratory and analytical processes required to support a planned uranium de-conversion and fluorine extraction facility. Radnostix, Inc. distributes its products directly to end-users as well as through a network of distributors.
The company was founded in 1995 and is headquartered in Idaho Falls, Idaho.
based on 542.15M shares outstanding
30d Avg
92.29K
60d Avg
78.14K
90d Avg
62.96K
Radnostix Inc. (OTC: INIS) traded at $0.0351 on Nov 17, 2026, down 8.83% from the previous close of $0.0385. 52-week range: $0.0302 to $0.0990. The company is in the Healthcare sector (Drug Manufacturers - Specialty & Generic).